Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2013

Nov 14, 2013

30071_dirs_2013-11-14_2b8a7b26-c37d-4f62-89e5-47040a137c38.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2013-11-11

Reporting Person: PENDARVIS DAVID (Chief Administrative Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-11-11 ResMed Common Stock F 2609 $50.74 Disposed 72321.566 Direct
2013-11-11 ResMed Common Stock F 2796 $50.74 Disposed 69525.566 Direct
2013-11-11 ResMed Common Stock F 2982 $50.74 Disposed 66543.566 Direct
2013-11-11 ResMed Common Stock F 1503 $50.74 Disposed 65040.566 Direct
2013-11-11 ResMed Common Stock M 3915 $25.540 Acquired 68955.566 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2013-11-11 ResMed Common Stock Options $25.54 M 3915 Acquired 2016-12-17 ResMed Common Stock (3915) Direct

Footnotes

F1: Disposition to issuer for tax withholding upon vesting of performance-based Restricted Stock Units granted on 12/17/2009 and vesting 11/11/2013.

F2: Includes 237.032 shares purchased on October 31, 2013, pursuant to ResMed's Employee Stock Purchase Plan.

F3: Disposition to issuer for tax withholding upon vesting of performance-based Restricted Stock Units granted on 11/11/2010 and vesting 11/11/2013.

F4: Disposition to issuer for tax withholding upon vesting of performance-based Restricted Stock Units granted on 11/16/2011 and vesting 11/11/2013.

F5: Disposition to issuer for tax withholding upon vesting of performance-based Restricted Stock Units granted on 11/15/2012 and vesting 11/11/2013.

F6: Represents date options first became available. Options vest 1/4 per year on the anniversary of the grant.